Literature DB >> 34064812

Preparation of the Key Dolutegravir Intermediate via MgBr2-Promoted Cyclization.

Jiahui Kong1,2, Haijian Xia2, Renbao He2, Hao Chen2, Yongping Yu1.   

Abstract

A novel approach for synthesizing the key dolutegravir intermediate is described via MgBr2-promoted intramolecular cyclization. Condensation of commercially available methyl oxalyl chloride and ethyl 3-(N,N-dimethylamino)acrylate afforded the vinylogous amide in an excellent yield. Subsequent substitution by aminoacetaldehyde dimethyl acetal and methyl bromoacetate gave rise to the expected precursor for cyclization, which was promoted by MgBr2 to highly selectively convert into pyridinone diester. The key dolutegravir intermediate was finally prepared by the selective hydrolysis of the corresponding diester via LiOH.

Entities:  

Keywords:  MgBr2-promoted cyclization; chemoselectivity; dolutegravir

Year:  2021        PMID: 34064812      PMCID: PMC8150840          DOI: 10.3390/molecules26102850

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  11 in total

Review 1.  Metal-free multicomponent reactions: a benign access to monocyclic six-membered N-heterocycles.

Authors:  Krishna Nand Singh
Journal:  Org Biomol Chem       Date:  2021-03-08       Impact factor: 3.876

2.  An efficient and highly diastereoselective synthesis of GSK1265744, a potent HIV integrase inhibitor.

Authors:  Huan Wang; Matthew D Kowalski; Ami S Lakdawala; Frederick G Vogt; Lianming Wu
Journal:  Org Lett       Date:  2015-01-23       Impact factor: 6.005

3.  Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.

Authors:  Joel E Gallant; Ellen Koenig; Jaime Andrade-Villanueva; Ploenchan Chetchotisakd; Edwin DeJesus; Francisco Antunes; Keikawus Arastéh; Graeme Moyle; Giuliano Rizzardini; Jan Fehr; Yapei Liu; Lijie Zhong; Christian Callebaut; Javier Szwarcberg; Martin S Rhee; Andrew K Cheng
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

4.  Carbamoyl pyridone HIV-1 integrase inhibitors. 2. Bi- and tricyclic derivatives result in superior antiviral and pharmacokinetic profiles.

Authors:  Takashi Kawasuji; Brian A Johns; Hiroshi Yoshida; Jason G Weatherhead; Toshiyuki Akiyama; Teruhiko Taishi; Yoshiyuki Taoda; Minako Mikamiyama-Iwata; Hitoshi Murai; Ryuichi Kiyama; Masahiro Fuji; Norihiko Tanimoto; Tomokazu Yoshinaga; Takahiro Seki; Masanori Kobayashi; Akihiko Sato; Edward P Garvey; Tamio Fujiwara
Journal:  J Med Chem       Date:  2013-01-22       Impact factor: 7.446

5.  Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore.

Authors:  Takashi Kawasuji; Brian A Johns; Hiroshi Yoshida; Teruhiko Taishi; Yoshiyuki Taoda; Hitoshi Murai; Ryuichi Kiyama; Masahiro Fuji; Tomokazu Yoshinaga; Takahiro Seki; Masanori Kobayashi; Akihiko Sato; Tamio Fujiwara
Journal:  J Med Chem       Date:  2012-10-04       Impact factor: 7.446

6.  Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity.

Authors:  A A Mathias; P German; B P Murray; L Wei; A Jain; S West; D Warren; J Hui; B P Kearney
Journal:  Clin Pharmacol Ther       Date:  2009-12-30       Impact factor: 6.875

7.  Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?

Authors:  Marco Vitoria; Andrew M Hill; Nathan P Ford; Meg Doherty; Saye H Khoo; Anton L Pozniak
Journal:  J Int AIDS Soc       Date:  2016-02-02       Impact factor: 5.396

8.  7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir.

Authors:  Robert E Ziegler; Bimbisar K Desai; Jo-Ann Jee; B Frank Gupton; Thomas D Roper; Timothy F Jamison
Journal:  Angew Chem Int Ed Engl       Date:  2018-05-14       Impact factor: 15.336

9.  Synthesis and Antiviral Evaluation of (1,4-Disubstituted-1,2,3-Triazol)-(E)-2-Methyl-but-2-Enyl Nucleoside Phosphonate Prodrugs.

Authors:  Tuniyazi Abuduaini; Vincent Roy; Julien Marlet; Catherine Gaudy-Graffin; Denys Brand; Cécile Baronti; Franck Touret; Bruno Coutard; Tamara R McBrayer; Raymond F Schinazi; Luigi A Agrofoglio
Journal:  Molecules       Date:  2021-03-09       Impact factor: 4.411

10.  Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine.

Authors:  Shrika G Harjivan; Catarina Charneira; Inês L Martins; Sofia A Pereira; Guadalupe Espadas; Eduard Sabidó; Frederick A Beland; M Matilde Marques; Alexandra M M Antunes
Journal:  Molecules       Date:  2021-03-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.